In silico study on evaluation of corosolic acid of Lagerstroemia speciosa against Alzheimer’s disease
Open Access
- 2 December 2022
- journal article
- research article
- Published by Emerald Publishing in Arab Gulf Journal of Scientific Research
- Vol. 41 (2) , 175-182
Abstract
Alzheimer’s disease (AD), the most common cause of dementia, is a neurodegenerative disorder caused by the aggregation of amyloid-beta (Aβ) at outside of neuron cells and also due to tau aggregation inside the cell. Corosolic acid is aimed to be selected as a main active constituent of Lagerstroemia speciosa for the study. In the present study, molecular docking of corosolic acid and tau protein was examined using PyRx-v.0.8 software. Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties were described and a molecular dynamics study of the bound complex was performed using Desmond. The docking score and interactions suggested that the corosolic acid (CID:6918774) could bind to tau protein to prevent the fibrillar network, to prevent AD. During simulation corosolic acid-bound protein root mean square deviation (RMSD) values showed more stability when compared to the Apo form of protein. Molecular dynamics study of tau protein and corosolic acid complex gave the insights to develop a drug-like candidate against AD. The use of corosolic acid of Lagerstroemia speciosa to prevent AD is supported by preliminary analysis on a computational basis. This compound should explore in terms of experimental strategies for the further drug development process. However, in vitro and in vivo evaluation studies are required to suggest the use of corosolic acid against AD.Keywords
This publication has 10 references indexed in Scilit:
- Role of tau protein in Alzheimer's disease: The prime pathological playerInternational Journal of Biological Macromolecules, 2020
- New Insights Into the Pathogenesis of Alzheimer's DiseaseFrontiers in Neurology, 2020
- Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s diseaseDrug Design, Development and Therapy, 2018
- Large-scale prediction of binding affinity in protein–small ligand complexes: the PRODIGY-LIG web serverBioinformatics, 2018
- Oxidative stress and the amyloid beta peptide in Alzheimer’s diseaseRedox Biology, 2018
- Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors ofMycobacterium tuberculosisisocitrate lyaseJournal of Biomolecular Structure and Dynamics, 2017
- A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modelingClimacteric, 2017
- Methods of Protein Structure Comparison2011
- Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s DiseasesMolecular Medicine, 2008
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997